Swine Healthcare Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Products (Diagnostic Tests and Therapeutics), Diseases, and Geography

Market Snapshot

swine health market animal disease diagnostic genetics industry
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

13.5 %

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The global swine health market is expected to register a healthy CAGR during the forecast period, owing to the increasing incidence of swine diseases. China Ministry of Agriculture and Rural Affairs (MARA) confirmed its first African swine fever (ASF) outbreak in Liaoning Province in 2018, 145 ASF outbreaks detected in 32 Provinces/Autonomous Regions/Municipalities/Special Administrative Region. More than 1,160,000 pigs have been rising investments in R&D activities in the development of novel therapeutics, a growing number of governments initiatives for the prevention of zoonotic diseases, increasing demand for livestock products is expected to propel the global swine health market.  culled in an effort to halt the further spread. Additionally, the growing consumption of pork globally.

Scope of the Report

As per the scope, swine health is associated with various diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to many diseases such as reproductive disease and congenital malformations. Pig production is an important component of global food security, agricultural economies, and local and international trade. Infectious diseases impact pig health and the stability and productivity of the global swine industry.

By products
Diagnostic Tests
Enzyme Linked Immuno-Sorbent Assay (ELISA)
Rapid Immuno Migration (RIM)
Agar Gel Immuno-Diffusion (AGID)
Polymerase Chain Reaction (PCR)
Diagnostic Imaging
Therapeutics
Vaccines
Parasiticide
Anti-infective
Feed additives
Antibiotics
Others
By Diseases
Exudative dermatitis (greasy pig disease)
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines are Expected to Lead the Market

Vaccines are comprised of viruses, bacteria or other disease-causing organisms that have been killed or altered. Hence, they cannot cause any disease and boost up immunity. New advanced vaccines have been manufactured, which contains genetically engineered components derived from those disease agents. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most of the vaccines stimulate both a humoral response and a cell-mediated response. Vaccines can be live, containing living organisms which will multiply in the pig, or inactivated, containing only killed organisms which will not multiply in the pig. As there is a need for novel vaccines against all the disease-causing pathogens, there is a rapid increase in the R&D expenditure, which drives the vaccine segment to expand its reach to a broad spectrum of diseases.

swine health market animal disease diagnostic genetics industry

To understand key trends, Download Sample Report

North America is Expected to Dominate over the Forecast Period

North America is expected to dominate the market due to the rising incidence of swine infections, such as Swine Enteric Coronavirus Diseases (SECD), porcine epidemic diarrhea (PEDv), porcine delta coronavirus (PDCoV), which has caused significant morbidity and mortality, particularly in young piglets. The virus is endemic in swine populations in North America. In the United States, the Swine Health Protection Act (SHPA) regulates the meat products fed to swine. Compliance with this act ensures that all food waste fed to swine is properly treated to kill disease organisms. Raw meat may transmit numerous infectious or communicable diseases to swine. Over the forecast period, with the rise in the incidence of swine, the US is expected to be a major revenue generating region for the swine health market.

swine health market animal disease diagnostic genetics industry

To understand geography trends, Download Sample Report

Competitive Landscape

The market players in the swine health market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions in order to enhance the market presence. For instance, in 2018 Elanco Animal Health, introduced Prevacent PRRS a modified-live respiratory vaccine for reduction of porcine reproductive and respiratory syndrome (PRRS), respiratory form, in piglets two weeks or older. In May 2019, MSD Animal Health has launched its Porcilis Ery+Parvo+Lepto combination vaccine for pigs.

Major Players

  1. Zoetis animal healthcare
  2. Merck Animal Health
  3. IDVet
  4. Elanco
  5. Ceva Animal Health Inc.

* Complete list of players covered available in the table of contents below

swine health market animal disease diagnostic genetics industry

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing incidence of swine diseases

      2. 4.2.2 Increasing demand for livestock products

      3. 4.2.3 Increasing investments in R&D activities to develop novel therapeutics

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Challenges

      2. 4.3.2 High cost associated with swine health especially in the developing countries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By products

      1. 5.1.1 Diagnostic Tests

        1. 5.1.1.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)

        2. 5.1.1.2 Rapid Immuno Migration (RIM)

        3. 5.1.1.3 Agar Gel Immuno-Diffusion (AGID)

        4. 5.1.1.4 Polymerase Chain Reaction (PCR)

        5. 5.1.1.5 Diagnostic Imaging

      2. 5.1.2 Therapeutics

        1. 5.1.2.1 Vaccines

        2. 5.1.2.2 Parasiticide

        3. 5.1.2.3 Anti-infective

        4. 5.1.2.4 Feed additives

        5. 5.1.2.5 Antibiotics

        6. 5.1.2.6 Others

    2. 5.2 By Diseases

      1. 5.2.1 Exudative dermatitis (greasy pig disease)

      2. 5.2.2 Coccidiosis

      3. 5.2.3 Respiratory diseases

      4. 5.2.4 Swine dysentery

      5. 5.2.5 Porcine parvovirus

      6. 5.2.6 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 US

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 UK

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abaxis

      2. 6.1.2 Bayer Animal Health

      3. 6.1.3 Boehringer Ingelheim

      4. 6.1.4 Ceva Animal Health Inc.

      5. 6.1.5 Elanco

      6. 6.1.6 IDVet

      7. 6.1.7 Merck Animal Health

      8. 6.1.8 Merial

      9. 6.1.9 Vetoquinol S.A.

      10. 6.1.10 Virbac

      11. 6.1.11 Zoetis animal healthcare

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information